会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Dihydro- and tetrahydro-quinoline compounds
    • 二氢 - 和四氢 - 喹啉化合物
    • US06350759B1
    • 2002-02-26
    • US09425267
    • 1999-10-22
    • Patrick CasaraGilbert DoreyPierre LestageBrian Lockhart
    • Patrick CasaraGilbert DoreyPierre LestageBrian Lockhart
    • A61K3147
    • C07D221/20C07D215/20C07D401/06C07D471/10
    • Compound of formula (I): wherein: R1 represents hydrogen or wherein A is as defined in the description, R2 and R3 each independently represents alkyl, cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl,or optionally substituted aminoalkyl or R2 and R3, together with the carbon atom carrying them, form cycloalkyl or monocyclic heterocyclic group, substituted or unsubstituted, R40 represents hydrogen or a group selected from optionally substituted alkyl, optionally substituted alkenyl and optionally substituted alkynyl or Q or —V—Q wherein V represents alkylene, alkenylene or alkynylene and Q represents optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocycloalkyl,or optionally substituted heteroaryl, R41 and R5 together form a bond or each represents hydrogen, R6, R7, R8 and R9 each independently represents hydrogen, halogen, alkyl, (C3-C8)cycloalkyl,or —OW wherein W is as defined in the description, and medicinal products containing the same which are useful as antioxidative agents.
    • 式(I)化合物:其中:R1表示氢,或者其中A如说明书中所定义,R 2和R 3各自独立地表示烷基,环烷基,杂环烷基,任选取代的芳基,任选取代的杂芳基,环烷基烷基,杂环烷基烷基,任选取代的芳基烷基, 取代的杂芳基烷基或任选取代的氨基烷基或R 2和R 3与携带它们的碳原子一起形成取代或未取代的环烷基或单环杂环基,R 40表示氢或选自任选取代的烷基,任选取代的烯基和任选取代的炔基 或Q或-VQ,其中V表示亚烷基,亚烯基或亚炔基,Q表示任选取代的环烷基,任选取代的芳基,任选取代的杂环烷基或任选取代的杂芳基,R 41和R 5一起形成键或各自表示氢,R6,R7,R8 和R9各自独立地 呈现氢,卤素,烷基,(C 3 -C 8)环烷基或-OW,其中W如说明书中所定义,以及含有该化合物的药物,其可用作抗氧化剂。
    • 2. 发明授权
    • Cycloheptene compounds
    • 环庚烯化合物
    • US06638962B2
    • 2003-10-28
    • US10050666
    • 2002-01-16
    • Patrick CasaraThierry Le DiguarherGilbert DoreyJohn HickmanAlain PierreGordon TuckerNicolas Guilbaud
    • Patrick CasaraThierry Le DiguarherGilbert DoreyJohn HickmanAlain PierreGordon TuckerNicolas Guilbaud
    • A61K314174
    • C07D233/64A61K31/4164C07D213/38C07D401/06
    • Compound of formula (I): wherein: X represents a bond or alkylene, CO, S(O)n, —S(O)n—A1—, —CO—A1—, —A—S(O)n—A′1— or —A1—CO—A′1—, Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted, R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted, or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle, T represents —CH(R5)—, —N(R5)— or —N(R5)CO—, V represents hydrogen or unsubstituted or substituted aryl or heteroaryl, A2 represents [C(R6)(R′6)]p, R7 and R8 are as defined in the description, their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
    • 式(I)的化合物:其中:X表示键或亚烷基,CO,S(O)n,-S(O)n -A1,-CO-A1-,-AS(O)n-A'1 - 或-A1-CO-A'1-,Y表示芳基,杂芳基,环烷基或杂环烷基,每个未取代或取代的,R 1,R 2,R 3和R 4各自独立地表示氢或芳基,杂芳基,环烷基或杂环烷基, 每个未取代或取代的或R 1,R 2,R 3和R 4成对取代,一起形成键,或形成稠合苯环或稠合芳族或部分不饱和杂环,T表示-CH(R 5) - , - N( R5) - 或-N(R5)CO-,V表示氢或未取代或取代的芳基或杂芳基,A2表示[C(R6)(R'6)] p,R7和R8如说明书中所定义, 并且其与药学上可接受的酸或碱的加成盐和含有它们的药物可用作法呢基转移酶抑制剂。